Search
Search Results
-
Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas
Cancer-associated stroma (CAS) is widely recognized to influence development and progression of epithelial tumours including breast cancer. Canine...
-
Health-related quality of life among prostate cancer survivors with metastatic disease and non-metastatic disease and men without a cancer history in the USA
BackgroundFew studies have comprehensively compared health-related quality of life (HRQoL) between metastatic prostate cancer survivors, survivors...
-
Analysis of serum peptidome profiles of non-metastatic and metastatic feline mammary carcinoma using liquid chromatography-tandem mass spectrometry
BackgroundFeline mammary carcinoma (FMC) is a common aggressive and highly metastatic cancer affecting female cats. Early detection is essential for...
-
Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma
BackgroundAdrenocortical carcinoma (ACC) is an aggressive, deadly malignancy. Resection remains the primary treatment; however, there is conflicting...
-
Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer
PurposeProstate cancer (PCa) lacks specific markers capable of distinguishing aggressive tumors from those with indolent behavior. Therefore, the aim...
-
Predictors for temporary stomas non-closure among non-metastatic rectal cancer patients undergoing curative resection: a retrospective analysis
BackgroundThe primary treatment for non-metastatic rectal cancer is curative resection. However, sphincter-preserving surgery may lead to...
-
The prognostic role of perirenal fat tissue in non-metastatic renal cell carcinoma
PurposeThe aim of this study was to evaluate the impact of perirenal fat volume and perirenal fat density on prognosis in surgically treated...
-
The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study
PurposeThe aim of this study was to explore the benefit the metastasectomy for patients with metastatic non-clear cell carcinoma (non-ccRCC).
...
-
Conditional survival nomogram for monitoring real-time survival of young non-metastatic nasopharyngeal cancer survivors
BackgroundThe aim of this study was to clarify the improvement of the overall survival (OS) over time in young non-metastatic nasopharyngeal...
-
The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China
IntroductionSugemalimab is the first China-developed programmed death-ligand 1 inhibitor that has proved to be effective as a first-line treatment...
-
Prognostic value of preoperative microscopic hematuria in patients with non-metastatic renal cell carcinoma who underwent nephrectomy
BackgroundMicroscopic hematuria is associated with various urinary system diseases and is commonly used for the diagnosis of these conditions. Its...
-
Clinical experience of consolidative radiotherapy for localized metastatic non-small cell lung cancer who showed favorable tumor response after systemic treatment
BackgroundOur study has aimed to assess the effects of consolidative high-dose radiotherapy on clinical outcomes in patients with localized...
-
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy
BackgroundFor patients with metastatic non-small cell lung cancer, timely molecular testing is essential to determine the appropriate course of...
-
Pre-operative Radiation and Immunotherapy in the Treatment of Non-metastatic Breast Cancer
Purpose of ReviewTo discuss the rationale and latest strategies for combining pre-operative radiation therapy (pre-op RT) and immunotherapy (IO) in...
-
Conditional Overall Survival After Diagnosis of Non-Metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status
BackgroundThe prognostic relevance of laterality, microsatellite instability (MSI), and KRAS status in colon cancer has been established. However,...
-
Non-metastatic hip fractures surgery in patients with active cancer: benefit and risk
PurposeAlthough rare, non-metastatic proximal femoral fracture (PFF) can develop in patients with active cancer. However, little data are available...
-
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients
PurposeData about optimal management of plasmacytoid (PCV) bladder cancer patients are extremely scarce and limited by sample size. We focused on PCV...
-
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
According to current guidelines, targeted therapy with a combination of BRAF plus MEK inhibitors is the preferred first-line treatment for patients...
-
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus
BackgroundTo reach a consensus on recommendations for the management of high-risk and post-operative non-metastatic prostate cancer by a group of...
-
Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer
PurposeTo evaluate the association between preoperative pan-immune inflammation value (PIV) and overall survival (OS) and disease-free survival (DFS)...
